Commentary: Aspirin and cancer prevention

International Journal of Epidemiology

Volumn 36, Issue 5, 2007, Pages 957-959

  Kune, Gabriel ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; STEROID; TRANQUILIZER;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUSTRALIA; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; GASTROINTESTINAL HEMORRHAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOW DRUG DOSE; NONHUMAN; NOTE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; HUMANS;

EID: 35548994546     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym194     Document Type: Note

References (18)

1. Kune GA, Kune S, Watson LF. Colorectal cancer, chronic illnesses, operations, and medications. Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-404. Reprinted Int J Epidemiol 2007;36:951-57.
2. Thun MJ, Namboodiri MM, Heath CR Jr. Aspirin use and reduced risk of fatal colon cancer. N Enyl J Med 1991;325:1593-96.
3. Rosenberg L, Palmer JR. Zanberg AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: Non-steroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-58.
4. International Agency for Reseaich on Cancer. IARC Hand book of Cancer Prevention. Non-steroidal anti-inflammatory drugs. Vol. 1 Lyon: IARC (WHO), 1997.
5. Kune G. Expert Review. Colorectal cancer chemoprevention with aspirin. Gastrointest Oncol 2002;4:5-14.
6. Bosetti G, Gallus S, La Vecchia. Aspirin and cancer risk: An updated quantitative review to 2005. Cancer Causes Control 2006;17 871-88.
7. Dube C, Rostom A, Lewin G et al. The use of aspirin for primary prevention of colorectal cancer: A systematic review prepared for the US. Preventive Services Task Force. Ann Intern Med 2007;146 365-75.
8. Flossman E, Rothwell PM. British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007;369:1603-13.
9. Hill AB. The environment and disease: Association or causation? Proc Roy Soc Med 1965;58:295-300.
10. Kim S, Baron JA, Mott LA et al. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control 2006;17:1299-304.
11. Bigler J, Whitton J, Lampe JW et al. CUP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 2001;61:3566-69.
12. Chan AT, Tranah GT, Giovannucci EL, Hunter DJ, Fuchs CS. Genetic variants in the UGTIA6 enzyme, aspirin use, and the risk of colorectal adenoma. J Natl Cancer Inst 2005;97:457-60.
13. Gao J, Liu Y, Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc Nad Acad Sci USA 2005;102:17207-12.
14. Baron JA, Cole BF, Sandler RS et al. A randomized trial of aspirin to prevent colorectal. adenomas. N Engl J Med 2003;348 891-99.
15. Chan AT, Giovannucci EL, Shernhammer ES et al. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med 2004;140:157-66.
16. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and non-steroidal anti-inflammatory drugs and risk of colorectal cancer. J Am Med Assoc 2005;294 944-23.
17. Barnes CJ, Hamby-Mason RL, Hardman WE, Cameron LL, Speeg KV, Lee MK. Effect of aspirin on prostaglandin E-2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon. Cancer Epidemial Biomarkers Prev 1999;8:311-15.
18. Pohle T, Brzozowski T, Becker JC et al. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther 2001;15 677-87.